![](https://d3ilqtpdwi981i.cloudfront.net/qVrWEjZD7OG41uKyKPlX0TLoawk=/0x5:225x296/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/e6/de/56/e6de56a0-e7c8-483e-a058-96b765af39dc/JOCO19.png)
Article
Vinorelbine Plus Capecitabine in a Heavily Pretreated HER2 Negative Metastatic Breast Cancer Patient Population: MCEPASTEBIN
Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting
(2018)
Disciplines
Publication Date
2018
Citation Information
Reshma Mahtani, A. Torres, C. Vogel, J. Ramdial, et al.. "Vinorelbine Plus Capecitabine in a Heavily Pretreated HER2 Negative Metastatic Breast Cancer Patient Population: MCEPASTEBIN" Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 36 Iss. 15 Suppl. (2018) Available at: http://works.bepress.com/reshma-mahtani/19/